We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 15 → 21 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405 → 527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$297M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$210M
3
State Street
State Street
Massachusetts
+$158M
4
Renaissance Technologies
Renaissance Technologies
New York
+$146M
5
Two Sigma Investments
Two Sigma Investments
New York
+$138M

Top Sellers

1
BlackRock
BlackRock
New York
-$315M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
-$284M
3
PAI
Palo Alto Investors
California
-$165M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$154M
5
American Century Companies
American Century Companies
Missouri
-$136M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
276
Teza Capital Management
Illinois
$1.64M +$1.45M +4,010 New
CI
277
Cavalier Investments
Georgia
$1.64M – – –
IHL
278
Investment House LLC
California
$1.64M – – –
FQ
279
First Quadrant
California
$1.63M -$499K -1,378 -26%
SLAM
280
Swiss Life Asset Management
$1.61M +$1.42M +3,930 New
NMERB
281
New Mexico Educational Retirement Board
New Mexico
$1.59M -$2.79M -7,700 -66%
CIBC Asset Management
282
CIBC Asset Management
Ontario, Canada
$1.52M +$811K +2,238 +152%
PAG
283
Private Advisor Group
New Jersey
$1.51M +$1.34M +3,700 New
Schroder Investment Management Group
284
Schroder Investment Management Group
United Kingdom
$1.51M -$2.56M -7,053 -66%
Parallax Volatility Advisers
285
Parallax Volatility Advisers
California
$1.48M +$1.31M +3,619 New
NCGI
286
Next Century Growth Investors
Minnesota
$1.48M -$18.3M -50,399 -93%
SIM
287
Spark Investment Management
New York
$1.47M +$1.3M +3,600 New
LCG
288
Lisanti Capital Growth
New York
$1.43M -$536K -1,480 -30%
CCM
289
Coe Capital Management
Illinois
$1.41M -$399K -1,101 -24%
CTC
290
Central Trust Company
Missouri
$1.4M +$325K +898 +36%
IG
291
ING Group
Netherlands
$1.33M +$1.18M +3,244 New
PAMG
292
Patton Albertson Miller Group
Tennessee
$1.32M +$1.17M +3,240 New
MC
293
Menta Capital
California
$1.32M +$681K +1,880 +140%
Commonwealth Equity Services
294
Commonwealth Equity Services
Massachusetts
$1.32M +$44.9K +124 +4%
Wealth Enhancement Advisory Services
295
Wealth Enhancement Advisory Services
Minnesota
$1.28M +$1.13M +3,111 New
BDS
296
Banco de Sabadell
Florida
$1.28M +$1.13M +3,120 New
CIBC World Market
297
CIBC World Market
Ontario, Canada
$1.28M -$927K -2,558 -45%
HMS
298
Hanseatic Management Services
New Mexico
$1.26M – – –
BBHC
299
Brown Brothers Harriman & Co
New York
$1.23M – – –
CANY
300
Caxton Associates (New York)
New York
$1.21M -$3.98K -11 -0.4%
10 11
12
13 14

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.